[Renoprotecion With Metabolic Syndrome: the Possibility of Receptor Agonist Imidazoline Moxonidine].

Ostroumova, O D; Zykova, A A

Ostroumova, O D; Zykova, A A.

Affiliation

Ostroumova OD; Sechenov First Moscow State Medical University, Moscow, Russia.
Zykova AA; A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia.

Kardiologiia ; 56(10): 72-79, 2016 10.

Article in Ru | MEDLINE | ID: mdl-28290898

Subject(s)

Antihypertensive Agents/therapeutic use; Imidazoles/therapeutic use; Imidazoline Receptors/agonists; Metabolic Syndrome; Animals; Humans; Hypertension; Kidney/drug effects; Kidney/physiopathology; Kidney Diseases/prevention & control; Metabolic Syndrome/drug therapy; Metabolic Syndrome/physiopathology; Sympathetic Nervous System/physiopathology

Key words

Metabolic syndrome; antihypertensive treatment; arterial hypertension; microalbuminuria; moxonidine; obesity

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Metabolic Syndrome / Imidazoline Receptors / Imidazoles / Antihypertensive Agents Type of study: Risk_factors_studies Limits: Animals / Humans Language: Ru Journal: Kardiologiia Year: 2016 Document type: Article Affiliation country: RUSSIA Country of publication: RUSSIA

Search on Google

Add to My VHL

XML

PubMed Links